Related Experiment Video
Updated: Apr 23, 2026

Assessing Therapeutic Angiogenesis in a Murine Model of Hindlimb Ischemia
Published on: June 8, 2019
The BEST-CLI trial: a multidisciplinary effort to assess which therapy is best for patients with critical limb
Alik Farber1, Kenneth Rosenfield2, Matthew Menard3
1Division of Vascular and Endovascular Surgery, Boston Medical Center, Boston, MA.
Insights
The BEST-CLI trial compares endovascular therapy to open surgery for critical limb ischemia (CLI), aiming to guide treatment decisions for patients with peripheral arterial disease and prevent limb loss.
Area of Science:
- Vascular Surgery
- Interventional Cardiology
- Peripheral Arterial Disease Management
Background:
- Critical limb ischemia (CLI) is the most severe form of peripheral arterial disease, carrying a high risk of limb loss.
- Current treatment involves limb revascularization, with ongoing debate regarding the optimal approach between open vascular bypass and endovascular therapy for infrainguinal disease.
- A lack of comparative effectiveness data has hindered definitive treatment guidance for CLI patients eligible for both interventions.
Purpose of the Study:
- To compare the effectiveness of the best available endovascular therapy versus the best available open surgical treatment in patients with CLI who are eligible for both procedures.
- To provide urgently needed clinical guidance for the management of critical limb ischemia.
- To evaluate the cost-effectiveness and quality-of-life outcomes of both treatment strategies.
Main Methods:
- The Best Endovascular versus Best Surgical Therapy in patients with CLI (BEST-CLI) trial is a pragmatic, multicenter, open-label, randomized trial.
- It compares best endovascular therapy against best open surgical treatment in patients eligible for both.
- The trial employs a novel primary endpoint including limb amputation rates, repeat interventions, and mortality.
Main Results:
- The study is designed to provide comparative effectiveness data for CLI management.
- It allows for the incorporation of newer therapies as they emerge.
- The trial facilitates a multidisciplinary approach involving various vascular specialists.
Conclusions:
- The BEST-CLI trial is expected to resolve clinical equipoise regarding endovascular versus surgical revascularization for CLI.
- Findings will inform clinical decision-making for patients with peripheral arterial disease and critical limb ischemia.
- The study will offer crucial insights into optimizing limb salvage and patient outcomes.
Abstract:
Critical limb ischemia (CLI) is the most severe form of peripheral arterial disease and is associated with a significant risk of limb loss. It is currently treated with limb revascularization by a variety of specialists. Although both open vascular bypass and endovascular therapy are offered to patients with infrainguinal peripheral arterial disease and CLI, significant disagreement exists as to which therapy works best in candidates for both types of intervention. Persistent clinical equipoise in combination with a paucity of comparative effectiveness data to guide treatment of CLI has led to a multidisciplinary effort to organize the Best Endovascular versus Best Surgical Therapy in patients with CLI (BEST-CLI) trial. The BEST-CLI trial is a pragmatic, multicenter, open label, randomized trial that compares best endovascular therapy with best open surgical treatment in patients eligible for both treatments. This trial is highly innovative in both its design and its collaborative nature. BEST-CLI aims to provide urgently needed clinical guidance for CLI management by using (1) a pragmatic design comparing the effectiveness of established techniques while allowing for the introduction of newer therapies as they become available; (2) a novel primary end point that includes limb amputation rates, repeat intervention, and mortality; (3) a multidisciplinary structure that fosters cooperation among interventional cardiologists, interventional radiologists, vascular surgeons, and vascular medicine specialists; and (4) novel techniques to evaluate the cost-effectiveness and quality-of-life outcomes of the 2 treatment strategies being tested.
More Related Videos
07:25Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
09:56A Rat Model of Tibial Cortex Transverse Transport for the Treatment of Lower Limb Ischemia
Published on: March 6, 2026
Related Concept Videos
Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease IV: Nursing Management
Peripheral Artery Disease V: Postoperative Nursing Management
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Acute Coronary Syndrome IV: Interprofessional Care